StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.27−0.02 (-0.47%)

Close on Nov 18, 2026Market cap $1.53BP/E –Yield –

Precigen pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Precigen's pe ratio was 7.5× on Oct 31, 2023.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Oct 31, 20237.5×−5.1
2022Dec 30, 202212.7×–

More Precigen figures

See a number that looks wrong?